Familial Partial Lipodystrophy Latest Advances

Find the Latest Research About Familial Partial Lipodystrophy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 358 publications

Lipemia Retinalis Reversal in Familial Partial Lipodystrophy.

Lipemia Retinalis Reversal in Familial Partial Lipodystrophy.

Journal: JAMA ophthalmology

Published: September 03, 2026

The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype-specific.

The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype-specific.

Journal: JCI insight

Published: July 16, 2026

Molecular insight into the activator and deactivator mutations of peroxisome proliferator-activated receptor gamma.

Molecular insight into the activator and deactivator mutations of peroxisome proliferator-activated receptor gamma.

Journal: Journal of biomolecular structure & dynamics

Published: June 05, 2026

A Rare Instance of Concordant Charcot-Marie-Tooth Disease and Familial Partial Lipodystrophy Type 2.

A Rare Instance of Concordant Charcot-Marie-Tooth Disease and Familial Partial Lipodystrophy Type 2.

Journal: Cureus

Published: May 21, 2026

Clinical and metabolic characteristics of acquired partial lipodystrophy: insights from a multicenter study.

Clinical and metabolic characteristics of acquired partial lipodystrophy: insights from a multicenter study.

Journal: Journal of endocrinological investigation

Published: May 19, 2026

Acanthosis nigricans as a diagnostic clue for familial partial lipodystrophy type 2: a case report with review of literature on Japanese cases.

Acanthosis nigricans as a diagnostic clue for familial partial lipodystrophy type 2: a case report with review of literature on Japanese cases.

Journal: Endocrine journal

Published: May 13, 2026

First diagnosis of familial partial lipodystrophy syndrome type 3 during pregnancy associated with a novel heterozygous PPARG variant and a concurrent ABCC8 variant: a case report.

First diagnosis of familial partial lipodystrophy syndrome type 3 during pregnancy associated with a novel heterozygous PPARG variant and a concurrent ABCC8 variant: a case report.

Journal: Frontiers in endocrinology

Published: April 14, 2026

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network.

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network.

Journal: Diabetes, obesity & metabolism

Published: April 09, 2026

Lipodystrophies in Clinical Practice: A Case Series From a Local Health Unit in Portugal.

Lipodystrophies in Clinical Practice: A Case Series From a Local Health Unit in Portugal.

Journal: Cureus

Published: February 17, 2026

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Journal: Diabetes & metabolism

Published: February 13, 2026

Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy, Dunnigan variety due to heterozygous LMNA variants.

Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy, Dunnigan variety due to heterozygous LMNA variants.

Journal: Journal of the Endocrine Society

Published: February 06, 2026

A Novel PPARG R212W Variant Causes Familial Partial Lipodystrophy Type 3: Clinical Presentation and Functional Characterization.

A Novel PPARG R212W Variant Causes Familial Partial Lipodystrophy Type 3: Clinical Presentation and Functional Characterization.

Journal: International journal of molecular sciences

Published: January 15, 2026

Showing 1-12 of 358

Last Updated: 09/26/2026